EDN1 and glomerulosclerosis: Much of the evidence for ET-1–induced glomerular injury has been provided by studies demonstrating beneficial effects of ET receptor inhibition or kidney cell–specific ET receptor knockout in models of diseases that lead to glomerulosclerosis [6].